PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Bendy tubes get around

Rice-led researchers settle argument over mobility of flexible filaments

2011-01-08
(Press-News.org) Theo Odijk, you win. The professor of biotechnology at Delft University of Technology in the Netherlands has a new best friend in Rice University's Matteo Pasquali.

Together with collaborators at the French National Center for Scientific Research (CNRS), the University of Bordeaux, France, and Vrije University, Amsterdam, the Rice professor and his team have settled a long-standing controversy in the field of polymer dynamics: The researchers proved once and for all that Odijk was correct in proclaiming that a little flexibility goes a long way for stiff filaments in a solution.

The study in the current issue of the journal Science shows that even a small ability to bend gives nanotubes and other tiny, stiff filaments the means to navigate through crowded environments, or even such fixed networks as cell matrices.

The work by Pasquali, a professor in chemical and biomolecular engineering and in chemistry, may bring about new ways to influence the motion of tiny filaments by tailoring their stiffness for a given environment.

Nanotubes are being studied for potential use in all kinds of sensing, even in the seemingly disparate fields of biological applications and oil exploration. In both, the ability of nanotubes and other fine, filamentous particles to move through their environments is critical, Pasquali said.

Understanding the motion of a single, flexible polymer chain in a network has been key to scientific advances by Odijk and others on, for example, the behavior of DNA. The Rice researchers expect their revelation to have no less impact.

Pasquali and lead author Nikta Fakhri, a former graduate student at Rice now doing postdoctoral research at the University of Gottingen, Germany, set out to break the deadlocked theories by Odijk and two other scientists who disagreed on the Brownian motion of stiff filaments in a crowded environment, and whether stiffness itself played any part.

"There's a long-standing, fundamental question: How does this threadlike object move when it gets crowded? It could be crowded because it's in a gel, or because there are a lot of threadlike objects with it -- which to that one object looks like a gel," he said.

Crowding constrains the ability of a filament to travel. Think of trying to get from the back to the front of a crowded bus; it takes a certain amount of agility to weave your way through the packed bodies. "It turns out that with a little flexibility, a filament can explore the space around it much more effectively," Pasquali said.

That becomes important when the goal is to get filaments to find and enter a cellular pore to deliver a dose of medication or to act as a fluorescent sensor.

"If you look at the human body, they say we're made of 60 percent water, but we don't slosh around," Pasquali explained. "That's because the water is trapped in pores. Almost all the water in our body is in gel-like structures: inside our cells, which are laden with filamentous networks, or in the interstitial fluid surrounding these cells. We are a big, squishy, porous medium. We need to understand how the nanoparticles move in this medium."

Pasquali and Fakhri mimicked biological networks by using varying concentrations of agarose gel, a porous material often used as a filter in biochemistry and molecular biology for DNA and proteins. The gel forms a matrix of controllable size through which molecules can move.

Nanotubes served as a stand-in for any type of filament, albeit one whose stiffness can be controlled. Like a PVC pipe in the macro world, nanotubes get stiffer as they get thicker; but even the stiffest tubes can flex a bit with length, and these tubes were thousands of times longer than they were wide.

The study started somewhat serendipitously when co-author Laurent Cognet, a researcher at CNRS and the University of Bordeaux, tried to immobilize nanotubes in agarose gels. He noticed in a failed experiment that the nanotubes moved in a "funny way" and discussed it with Pasquali.

Pasquali asked whether the nanotubes were reptating -- scientist lingo for a snakelike motion -- and Cognet said yes. Fakhri, who was studying the dynamics of nanotubes, traveled to the Bordeaux laboratory of Cognet and co-author Brahim Lounis to capture images of the nanotubes in motion.

The resulting spectroscopic and direct still and video images of 35 fluorescent single-walled nanotubes showed them snaking through the gel, probing pores and paths. The nanotubes, like all filaments, obeyed the rules of thermal-induced Brownian motion; they were pushed and pulled by the ever-changing states of the molecules around them.

The research established that flexibility significantly enhances the nanotubes' ability to navigate around obstacles and speeds up their exploration.

Pasquali said Fakhri doggedly pursued her analysis of the nanotubes' motion through computerized image recognition and motion tracking, as well as old-fashioned pencil-and-paper dynamical analysis. He said his longtime collaborator, co-author Frederick MacKintosh, a theoretical physicist at Vrije University, was a tremendous help. MacKintosh has been studying the dynamics of biological networks for nearly two decades.

Pasquali intends to replace the gel with real rocks to see how nanotubes, which can be used as oil-detecting sensors, move in a more structured environment. "Rocks can be a little more complicated," he said. "The question here is, what can nanotubes do better than nanoparticles? The answer may be that slender nanotubes may interact with electromagnetic fields more strongly than other nanoparticles of the same volume."

###

The National Science Foundation Center for Biological and Environmental Nanotechnology, the Welch Foundation, the Advanced Energy Consortium, the Région Aquitaine, the Agence National pour la Recherche, the European Research Council and the Dutch Foundation for Fundamental Research on Matter supported the work.

Read the abstract at http://www.sciencemag.org/content/330/6012/1804.abstract

A video of a reptating nanotube can be viewed at http://www.sciencemag.org/content/330/6012/1804/suppl/DC1

END



ELSE PRESS RELEASES FROM THIS DATE:

Liver disease a possible predictor of stroke: Study

2011-01-08
TORONTO, Ont., January 7, 2011 — People suffering from fatty liver disease may be three times more likely to suffer a stroke than individuals without fatty liver, according to a study by researchers at St. Michael's Hospital and the London Health Sciences Centre. The study is the first to find a link between nonalcoholic fatty liver disease — a disease characterized by the accumulation of fat in the liver in non drinkers — and stroke. In a research letter to the editor in the journal Epidemiology released Thursday, Drs. Joel Ray, Ivan Ying and colleagues explain they ...

More than 3,000 survivors of the WTC attacks experience long-term post-traumatic stress disorder

2011-01-08
January 6, 2010 -- Nearly 10 years after the greatest human-made disaster in U.S. history-- the destruction of the World Trade Center (WTC) towers -- there has been little research documenting the attacks' consequences among those most directly affected -- the survivors who escaped the World Trade Center towers. In a study just released by Columbia University's Mailman School of Public Health, in conjunction with the New York City Department of Health and Mental Hygiene and the federal Agency for Toxic Substances Disease Registry (ATSDR), researchers found that of the ...

Grape ingredient resveratrol increases beneficial fat hormone

2011-01-08
SAN ANTONIO (Jan. 7, 2011) — Resveratrol, a compound in grapes, displays antioxidant and other positive properties. In a study published this week, researchers at the UT Health Science Center San Antonio describe a novel way in which resveratrol exerts these beneficial health effects. Resveratrol stimulates the expression of adiponectin, a hormone derived from cells that manufacture and store fat, the team found. Adiponectin has a wide range of beneficial effects on obesity-related medical complications, said senior author Feng Liu, Ph.D., professor of pharmacology and ...

Scientists shed light on what causes brain cell death in Parkinson's patients

2011-01-08
SAN ANTONIO (Jan. 7, 2011) — Just 5 percent of Parkinson's disease cases can be explained by genetic mutation, while the rest have no known cause. But a new discovery by researchers at The University of Texas Health Science Center San Antonio may begin to explain why the vast majority of Parkinson's patients develop the progressive neurodegenerative disease. This week in the Journal of Neuroscience, the researchers demystified a process that leads to the death of brain cells – or neurons – in Parkinson's patients. When researchers blocked the process, the neurons survived. The ...

MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia

2011-01-08
HOUSTON - The interplay between a major tumor-suppressing gene, a truncated chromosome and two sets of microRNAs provides a molecular basis for explaining the less aggressive form of chronic lymphocytic leukemia, an international team of researchers reports today in the Jan. 4 edition of the Journal of the American Medical Association. "Our findings could reveal new mechanisms of resistance to chemotherapy among leukemia patients as this feedback mechanism could help us differentiate between patients with poor or good prognosis," said co-senior author George Adrian Calin, ...

Study shows promise for new drug to treat Fragile X

2011-01-08
The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January 5 issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in the larger follow-up clinical trial. The data from the early trial of 30 Fragile X patients, found the drug, called AFQ056, made by Novartis Pharmaceuticals, helped improve symptoms in some patients. Patients who had ...

Blame the 'chaperone'

2011-01-08
A Jackson Laboratory research team led by Professor Patsy Nishina, Ph.D., has identified a mutation in a gene that's essential for correct protein-processing in cells. Defects in protein folding are associated with a variety of abnormalities and diseases. Cells don't come prefabricated, with pieces plunked down and tacked together like modular homes offloaded from trucks. The structural proteins that give cells shape, tubulin and actin (think beams and girders), are themselves subject to essential processing before they become part of the assembly. Proteins must be folded ...

Link between signaling molecules could point way to therapies for epilepsy, stroke, other diseases

2011-01-08
SAN ANTONIO (Jan. 7, 2010) — In the Old West, camps sent smoke signals across distances to share key developments or strategy. Likewise, two important signaling molecules communicate across nerve cells to regulate electrical and chemical activity, neuroscientists from the UT Health Science Center San Antonio reported today. The findings in rodent models have implications for potential future treatment of epilepsy, stroke and other problems, the researchers said. "We now have novel targets for therapeutic intervention for a range of neurological and cardiovascular diseases, ...

Prof. Erantha De Mel Receives The US President's Service Award

2011-01-08
Sri-Lankan born Psychologist / Cognitive Neuroscientist Prof. Erantha De Mel received the President's Call to Service Award at a ceremony held in Washington DC recently. This distinguished service award by President Barack Obama was presented to him for his outstanding services to the American community in the fields of Psychology and Psychotherapy. This lifetime achievement award was established in 2003 after President George W. Bush created the President's Council on Service and Civic Participation. It is given annually to individuals who have dedicated over 4,000 ...

GridBuddy: an award-winning cloud application for the Force.com platform

2011-01-08
Salesforce.com announced that AppBuddy's new application GridBuddy was recognized as one of the top 4 installed applications in the 'Hack into Dreamforce' contest. Awards were given to applications with the highest number of customer AppExchange software installs between 9/20/10 and 11/30/10 leading up to the annual Dreamforce conference. GridBuddy is a 100% native Force.com application that allows users to edit multiple related Salesforce objects using an Excel-like view. GridBuddy has a clean, simple-to-use interface for users to view one parent object with multiple ...

LAST 30 PRESS RELEASES:

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

[Press-News.org] Bendy tubes get around
Rice-led researchers settle argument over mobility of flexible filaments